HRI finds prison decongestion measures fall short from the commitments made in the name of public health.

Chang et al. call for an end to the criminalisation of drug use and the enactment of a new reality based on solidarity and cooperation, to protect the health and restore of the rights and dignity of people who use drugs.

The Ana Liffey Drug Project and the LSE shed light on the positive impact of pragmatic, comprehensive and tailored responses to the challenges posed by the COVID-19 pandemic, particularly for people in situations of vulnerability.

The 122 murders are the most obscene and tragic expression of a wider trend to erode the rights of children as part of the government's "war on drugs".

UNAIDS shows global HIV targets for 2020 will be missed, notes 1 in 10 new transmissions concern people who inject drugs.

ENPUD's seventh Information Digest focuses on communities response to the COVID-19 pandemic in the Eurasian region.

The survey identifies a range of issues such as the access to health and harm reduction services and the ongoing negative impact of criminalisation, stigma and discrimination on the lives of people who use drugs.

Thomas et al. discuss positive impact of needle and syringe programmes and low dead space syringes to limit new transmissions.

Reprieve and LBHM discuss contradictions between development goals and punitive drug policies, and the negative impact on social, economic and environmental outcomes.

EMCDDA reports an overall decline in drug use in Europe due to lockdown measures and shortages, although this varies strongly by drug type.

IDPC and TNI argue that the WHO’s recommendations will be an opportunity for African States to further decolonise drug control and strengthen the legal basis for emerging medicinal cannabis programmes.

HRI, SANPUD and Metzineres underscore the importance of alternatives to incarceration and the availability of humane, accessible and non-stigmatising services in prisons and the community.

HRI and SANPUD found law enforcement and prison staff attitudes and behaviours, including serious instances of violence, are a key obstacle.

AFEW International reports that although harm reduction and health organisations are adapting to pandemic restrictions, the continuity of prevention and treatment remains affected.

Transform and MUCD compare different aspects of regulation models in Canadian provinces, including licences, retail stores, age restrictions, prices, home-growing and remaining social inequalities.

Irvine et al. found that take‐home naloxone kits, supervised consumption sites and opioid agonist therapy have been effective in averting overdose deaths in British Columbia.

Unlu et al. argue that the impact of decriminalisation is heavily mediated by contextual factors, including investment in harm reduction and law enforcement involvement.

Kolla and Strike highlight the harm reduction potential of including some people who sell drugs in programmes.

AIN states that by addressing the underlying causes of coca cultivation, collaborative coca crop reductions in Bolivia proved to be more sustainable than those achieved under forced eradication.

CADTH found that injectable diacetylmorphine and injectable hydromorphone were more clinically and cost-effective than methadone.